Doxepin Hydrochloride
- Product NDC
- 63629-5033
- 11-digit product format
- 636295033
- Labeler code
- 63629
- Product ID
- 63629-5033_c7bcdac5-b245-4e00-b92d-5134fc2f5e03
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- doxepin hydrochloride
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Bryant Ranch Prepack
- Application
- ANDA070791
- Marketing category
- ANDA
- Marketing start
- 1986-05-13
- Substance
- DOXEPIN HYDROCHLORIDE
- Active strength
- 25 mg/1
- Pharmacologic classes
- Tricyclic Antidepressant [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Doxepin Hydrochloride
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| DOXEPIN HYDROCHLORIDE | 25 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 3U9A0FE9N5 |
| Rxcui | 1000070 |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
NDC, Effective, Action table| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|
| 63629-5033-1 | 2024-10-21 | C162847 | 48780-1 | 9d75b9d0-e794-f424-e053-dadaa90a57ce | Doxepin Hydrochloride Capsules, USP 10 mg, 25 mg, 50 mg, 75 mg and 100 mg* |
| 63629-5033-2 | 2024-10-21 | C162847 | 48780-1 | 9d75b9d0-e794-f424-e053-dadaa90a57ce | Doxepin Hydrochloride Capsules, USP 10 mg, 25 mg, 50 mg, 75 mg and 100 mg* |
| 63629-5033-3 | 2024-10-21 | C162847 | 48780-1 | 9d75b9d0-e794-f424-e053-dadaa90a57ce | Doxepin Hydrochloride Capsules, USP 10 mg, 25 mg, 50 mg, 75 mg and 100 mg* |
| 63629-5033-4 | 2024-10-21 | C162847 | 48780-1 | 9d75b9d0-e794-f424-e053-dadaa90a57ce | Doxepin Hydrochloride Capsules, USP 10 mg, 25 mg, 50 mg, 75 mg and 100 mg* |
| 63629-5033-5 | 2024-10-21 | C162847 | 48780-1 | 9d75b9d0-e794-f424-e053-dadaa90a57ce | Doxepin Hydrochloride Capsules, USP 10 mg, 25 mg, 50 mg, 75 mg and 100 mg* |
| 63629-5033-1 | 2024-01-30 | C162847 | 48780-1 | 9d75b9d0-e794-f424-e053-dadaa90a57ce | Doxepin Hydrochloride Capsules, USP 10 mg, 25 mg, 50 mg, 75 mg and 100 mg* |
| 63629-5033-2 | 2024-01-30 | C162847 | 48780-1 | 9d75b9d0-e794-f424-e053-dadaa90a57ce | Doxepin Hydrochloride Capsules, USP 10 mg, 25 mg, 50 mg, 75 mg and 100 mg* |
| 63629-5033-3 | 2024-01-30 | C162847 | 48780-1 | 9d75b9d0-e794-f424-e053-dadaa90a57ce | Doxepin Hydrochloride Capsules, USP 10 mg, 25 mg, 50 mg, 75 mg and 100 mg* |
| 63629-5033-4 | 2024-01-30 | C162847 | 48780-1 | 9d75b9d0-e794-f424-e053-dadaa90a57ce | Doxepin Hydrochloride Capsules, USP 10 mg, 25 mg, 50 mg, 75 mg and 100 mg* |
| 63629-5033-5 | 2024-01-30 | C162847 | 48780-1 | 9d75b9d0-e794-f424-e053-dadaa90a57ce | Doxepin Hydrochloride Capsules, USP 10 mg, 25 mg, 50 mg, 75 mg and 100 mg* |
| 63629-5033-1 | 2020-10-16 | C162847 | 48780-1 | 9d75b9d0-e794-f424-e053-dadaa90a57ce | Doxepin Hydrochloride Capsules, USP 10 mg, 25 mg, 50 mg, 75 mg and 100 mg* |
| 63629-5033-2 | 2020-10-16 | C162847 | 48780-1 | 9d75b9d0-e794-f424-e053-dadaa90a57ce | Doxepin Hydrochloride Capsules, USP 10 mg, 25 mg, 50 mg, 75 mg and 100 mg* |
| 63629-5033-3 | 2020-10-16 | C162847 | 48780-1 | 9d75b9d0-e794-f424-e053-dadaa90a57ce | Doxepin Hydrochloride Capsules, USP 10 mg, 25 mg, 50 mg, 75 mg and 100 mg* |
| 63629-5033-4 | 2020-10-16 | C162847 | 48780-1 | 9d75b9d0-e794-f424-e053-dadaa90a57ce | Doxepin Hydrochloride Capsules, USP 10 mg, 25 mg, 50 mg, 75 mg and 100 mg* |
| 63629-5033-5 | 2020-10-16 | C162847 | 48780-1 | 9d75b9d0-e794-f424-e053-dadaa90a57ce | Doxepin Hydrochloride Capsules, USP 10 mg, 25 mg, 50 mg, 75 mg and 100 mg* |
| 63629-5033-1 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-e794-f424-e053-dadaa90a57ce | Doxepin Hydrochloride Capsules, USP 10 mg, 25 mg, 50 mg, 75 mg and 100 mg* |
| 63629-5033-2 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-e794-f424-e053-dadaa90a57ce | Doxepin Hydrochloride Capsules, USP 10 mg, 25 mg, 50 mg, 75 mg and 100 mg* |
| 63629-5033-3 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-e794-f424-e053-dadaa90a57ce | Doxepin Hydrochloride Capsules, USP 10 mg, 25 mg, 50 mg, 75 mg and 100 mg* |
| 63629-5033-4 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-e794-f424-e053-dadaa90a57ce | Doxepin Hydrochloride Capsules, USP 10 mg, 25 mg, 50 mg, 75 mg and 100 mg* |
| 63629-5033-5 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-e794-f424-e053-dadaa90a57ce | Doxepin Hydrochloride Capsules, USP 10 mg, 25 mg, 50 mg, 75 mg and 100 mg* |
DailyMed Package Descriptions#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 63629-5033 | DOXEPIN HYDROCHLORIDE CAPSULE [BRYANT RANCH PREPACK] | 1014 | Current NDC, Legacy NDC, 5 package rows | 20241023_c577af7c-2405-4454-a169-5b6a4fa0c7bf.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 63629-5033-1 | 63629503301 | 30 CAPSULE in 1 BOTTLE (63629-5033-1) | 30 capsule | 2013-06-12 | 0000-00-00 | No | No | Current |
| 63629-5033-2 | 63629503302 | 60 CAPSULE in 1 BOTTLE (63629-5033-2) | 60 capsule | 2016-06-02 | 0000-00-00 | No | No | Current |
| 63629-5033-3 | 63629503303 | 28 CAPSULE in 1 BOTTLE (63629-5033-3) | 28 capsule | 2024-10-08 | 0000-00-00 | No | No | Current |
| 63629-5033-4 | 63629503304 | 18 CAPSULE in 1 BOTTLE (63629-5033-4) | 18 capsule | 2024-10-08 | 0000-00-00 | No | No | Current |
| 63629-5033-5 | 63629503305 | 90 CAPSULE in 1 BOTTLE (63629-5033-5) | 90 capsule | 2024-10-08 | 0000-00-00 | No | No | Current |